NextCure (NXTC) Capital Expenditures (2018 - 2024)
NextCure (NXTC) posted Capital Expenditures of -$34,000 for Q4 2024, compared with $13,000 a year earlier.
Analysis
NextCure (NXTC) Capital Expenditures (2018 - 2024) Analysis & Trends
For FY2024, NextCure's Capital Expenditures came in at $474,000, down 42.2% from FY2023.
- Annual Capital Expenditures has declined for four consecutive years, with a five-year compound annual growth rate of -32.5% (FY2019 to FY2024).
- In prior years, NextCure's Capital Expenditures was $820,000 in FY2023 (-61.2%), $2.12 million in FY2022 (-10.3%), $2.36 million in FY2021 (-66.9%) and $7.13 million in FY2020 (+111.6%).
- The Q4 2024 figure stands as the lowest quarterly Capital Expenditures in data going back to Q1 2018.
- On a year-over-year basis, Capital Expenditures increased in 1 of the last seven quarters, with an average decline of 44.8%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q3 2020, with growth of 282.2%; the weakest was Q4 2023, with a decline of 98.5%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $170,000 (Q3 2024), $301,000 (Q2 2024) and $37,000 (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 533.00 Mn |
| 10 | NextCure | 25.27 Mn | -95.48 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -34,000.00 |
| Sep 30, 2024 | 170,000.00 |
| Jun 30, 2024 | 301,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Dec 31, 2023 | 13,000.00 |
| Sep 30, 2023 | 279,000.00 |
| Jun 30, 2023 | 280,000.00 |
| Mar 31, 2023 | 248,000.00 |
| Dec 31, 2022 | 865,000.00 |
| Sep 30, 2022 | 532,000.00 |
| Jun 30, 2022 | 414,000.00 |
| Mar 31, 2022 | 305,000.00 |
| Dec 31, 2021 | 825,000.00 |
| Sep 30, 2021 | 556,000.00 |
| Jun 30, 2021 | 213,000.00 |
| Mar 31, 2021 | 766,000.00 |
| Dec 31, 2020 | 980,000.00 |
| Sep 30, 2020 | 1.87 Mn |
| Jun 30, 2020 | 2.83 Mn |
| Mar 31, 2020 | 1.45 Mn |
API Access
NextCure Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NXTC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "NXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=NXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();